首页 > 市场调查报告书 > 医疗设备

体外诊断

HIV诊断市场规模、份额和成长分析（按检测类型、产品类型、技术、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1919997

HIV诊断市场规模、份额和成长分析（按检测类型、产品类型、技术、最终用户和地区划分）－2026-2033年产业预测

HIV Diagnostics Market Size, Share, and Growth Analysis, By Test Type (Antibody Tests, Antigen Tests), By Product Type (Tests Kits, Instruments), By Technology, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年01月09日 | 出版商:

SkyQuest | 英文 191 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球 HIV 诊断市场规模预计在 2024 年达到 34 亿美元，从 2025 年的 35.5 亿美元成长到 2033 年的 50.5 亿美元，在预测期（2026-2033 年）内复合年增长率为 4.5%。

受爱滋病毒感染率上升和对准确快速诊断解决方案需求不断增长的推动，全球爱滋病毒诊断市场预计将迎来显着成长。推动该市场发展的关键因素包括就地检验技术的进步以及政府主导的旨在提高爱滋病毒认知和鼓励检测的各项倡议。快速检测套组的推出和分子诊断技术的推广应用正在促进市场扩张。北美凭藉其完善的医疗基础设施和高检测率，保持着市场主导地位；而亚太地区预计将成为增长最快的地区，这得益于医疗服务可及性的提高和公共倡议的推动。儘管存在这些积极趋势，但高昂的诊断成本、低收入地区检测服务可及性不足以及对爱滋病毒检测的持续歧视等挑战，可能会阻碍市场更广泛地接受该市场。

全球爱滋病毒诊断市场驱动因素

由于全球爱滋病感染病例显着增加，全球爱滋病诊断市场正经历强劲成长。感染人数的激增加剧了对可靠、早期和准确诊断解决方案的需求。为了满足这一迫切需求，医疗机构和政府部门正在加强筛检工作，有效推动了市场扩张。此外，这种积极主动的措施不仅促进了诊断技术的进步，也支持了各地区的持续成长，确保医疗卫生系统能够更好地应对日益严峻的爱滋病疫情带来的挑战。

全球爱滋病毒诊断市场限制因素

全球爱滋病毒诊断市场面临许多挑战，其中最主要的原因是现代检测技术成本高。儘管这些技术能够提供快速且准确的检测结果，但对许多人来说仍然遥不可及，尤其是在中低收入国家。核酸检测和自动化系统等先进检测方法需要对基础设施和熟练的人员进行大量投资。这种经济负担限制了这些创新诊断方法的广泛应用，并阻碍了它们融入医疗保健系统。因此，这种限制不仅影响了市场成长速度，也加剧了全球范围内获得基本诊断服务的差距。

全球爱滋病毒诊断市场趋势

全球爱滋病毒诊断市场正呈现出爱滋病毒自检检测套组日益普及的显着趋势。这些试剂盒为个人提供了一种便捷、私密且经济实惠的选择，在爱滋病毒污名化严重、医疗基础设施匮乏的地区尤其具有吸引力。自检检测套组可在家中轻鬆获得检测结果，有助于提高意识提升和促进早期诊断，从而有效鼓励更多人接受检测。这种以经济实惠和易于使用为特点的自检方式的兴起，正在扩大全球爱滋病毒诊断的覆盖范围，并推动市场显着成长。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Abbott Laboratories
F. Hoffmann-La Roche Ltd
Danaher Corporation
Becton, Dickinson and Company（BD）
Siemens Healthineers
Hologic, Inc.
Bio-Rad Laboratories, Inc.
bioMerieux SA
Thermo Fisher Scientific Inc.
OraSure Technologies, Inc.
Grifols, SA
QIAGEN NV
Chembio Diagnostic Systems, Inc.
Trinity Biotech plc
bioLytical Laboratories Inc.
Atomo Diagnostics
SD Biosensor, Inc.
Merck KGaA
J. Mitra & Co. Pvt. Ltd.
MedMira Inc.

结论与建议

简介目录

Product Code: SQMIG35J2180

Global HIV Diagnostics Market size was valued at USD 3.4 billion in 2024 and is poised to grow from USD 3.55 billion in 2025 to USD 5.05 billion by 2033, growing at a CAGR of 4.5% during the forecast period (2026-2033).

The global HIV diagnostics market is poised for substantial growth, driven by the rising prevalence of HIV infections and the heightened demand for accurate and timely diagnostic solutions. Key factors propelling this market include advancements in point-of-care testing technologies and increased government initiatives aimed at promoting HIV awareness and testing. The introduction of rapid testing kits and the expansion of molecular diagnostic methods are enhancing market reach. While North America maintains a dominant market share due to robust healthcare infrastructure and high testing rates, the Asia-Pacific region is anticipated to exhibit the fastest growth, supported by improved healthcare access and public policy initiatives. Despite these positive trends, challenges such as high diagnostic costs, accessibility issues in low-income regions, and lingering stigma surrounding HIV testing could impede broader market adoption.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global HIV Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global HIV Diagnostics Market Segments Analysis

Global HIV Diagnostics Market is segmented by Test Type, Product Type, Technology, End User and region. Based on Test Type, the market is segmented into Antibody Tests, Antigen Tests and Nucleic Acid Tests. Based on Product Type, the market is segmented into Tests Kits, Instruments and Software. Based on Technology, the market is segmented into Elisa, Rapid Testing and Polymerase Chain Reaction. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global HIV Diagnostics Market

The global HIV diagnostics market is experiencing robust growth due to a notable rise in HIV cases worldwide. This surge in infections has intensified the demand for dependable, early, and precise diagnostic solutions. In response to this pressing need, healthcare providers and governmental organizations have ramped up their screening initiatives, effectively driving market expansion. Furthermore, this proactive approach not only fosters advancements in diagnostic technology but also supports sustained growth in various regions, ensuring that healthcare systems are better equipped to address the challenges posed by the increasing prevalence of HIV.

Restraints in the Global HIV Diagnostics Market

The Global HIV Diagnostics market faces significant challenges due to the prohibitive costs associated with modern testing technologies, which, despite their ability to provide early and accurate results, remain out of reach for many, particularly in lower- and middle-income countries. Advanced testing methods, such as nucleic acid testing and automated systems, demand considerable investment in infrastructure and skilled personnel. This financial burden restricts the widespread adoption of these innovative diagnostics, hindering their integration into healthcare systems. Consequently, this limitation not only impacts the pace of market growth but also deepens disparities in access to essential diagnostic services worldwide.

Market Trends of the Global HIV Diagnostics Market

The global HIV diagnostics market is witnessing a significant trend towards the growing adoption of HIV self-testing kits. These kits offer a convenient, private, and affordable option for individuals, making them particularly appealing in regions where social stigma surrounding HIV persists or where healthcare infrastructure is lacking. By allowing users to receive results in the comfort of their homes, self-testing kits enhance awareness and facilitate early diagnosis, effectively encouraging more people to get tested. This shift towards self-testing, characterized by affordability and ease of use, is driving substantial growth and expanding access to HIV diagnostics on a global scale.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index, 2025
PESTEL Analysis
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Technology Assessment

Global HIV Diagnostics Market Size by Test Type & CAGR (2026-2033)

Market Overview
Antibody Tests
Antigen Tests
Nucleic Acid Tests

Global HIV Diagnostics Market Size by Product Type & CAGR (2026-2033)

Market Overview
Tests Kits
Instruments
Software

Global HIV Diagnostics Market Size by Technology & CAGR (2026-2033)

Market Overview
Elisa
Rapid Testing
Polymerase Chain Reaction

Global HIV Diagnostics Market Size by End-User & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostic Laboratories
Home Care Settings

Global HIV Diagnostics Market Size & CAGR (2026-2033)

North America (Test Type, Product Type, Technology, End-User)
- US
- Canada
Europe (Test Type, Product Type, Technology, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Test Type, Product Type, Technology, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Test Type, Product Type, Technology, End-User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Test Type, Product Type, Technology, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OraSure Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chembio Diagnostic Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioLytical Laboratories Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Atomo Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SD Biosensor, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
J. Mitra & Co. Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MedMira Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments